FDA Panel Rejects Use of MDMA for Treatment of PTSD
An independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress disorder.

Join our subscribers list to get the latest news, updates and special offers directly in your inbox
usnews Jul 4, 2024 0 245
usnews Jul 4, 2024 0 242
usnews Jul 4, 2024 0 241
usnews Jul 4, 2024 0 237
usnews Jul 4, 2024 0 236